CHEMLOK 8009B

2.1 Classification of the substance or mixture

Skin sensitization Category 1 Reproductive toxicity Category 1B Specific target organ systemic toxicity (single exposure) Category 1 Body, Respiratory system, Systemic toxicity Specific target organ systemic toxicity (repeated exposure) Category 1 Lungs, Respiratory system Hazardous to the aquatic environment - acute hazard Category 2 Hazardous to the aquatic environment - chronic hazard Category 2

Signal word

DANGER

Hazard statements

May cause an allergic skin reaction. May damage fertility or the unborn child. Causes damage to organs.(Body, Respiratory system, Systemic toxicity) Causes damage to organs through prolonged or repeated exposure.(Lungs, Respiratory system) Toxic to aquatic life. Toxic to aquatic life with long lasting effects.

Prevention

Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves. Use personal protective equipment as required. Do not breathe dust/fume/gas/mist/vapors/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment.

Response

300001006513 Get medical advice/attention if you feel unwell. IF exposed: Call a POISON CENTER or doctor/physician. Specific treatment (see supplemental first aid instructions on this label). IF ON SKIN: Wash with plenty of soap and water. If skin irritation or rash occurs: Get medical advice/attention. Wash contaminated clothing before reuse. Collect spillage.

Storage

Store locked up.

Disposal

Dispose of contents/container in accordance with waste/disposal laws and regulations of your country or particular locality.

2.3 Other hazards

This product contains component(s) which have the following warnings; however based on the GHS classification criteria of your country or locale, the product mixture may be outside the respective category(s). Acute: Vapor harmful; may affect the brain or nervous system causing dizziness, headache or nausea. May cause central nervous system depression characterized by the following progressive steps: headache, dizziness, staggering gait, confusion, unconsciousness or coma. Possible irritation of the respiratory system can occur causing a variety of symptoms such as dryness of the throat, tightness of the chest, and shortness of breath. May cause skin and eye irritation. May be harmful if swallowed. Ingestion is not an expected route of entry in industrial or commercial uses. Chronic: Prolonged or repeated contact may result in dermatitis. Repeated or prolonged solvent overexposure may result in permanent central nervous system damage. Formaldehyde may be released from this product in processes that involve heat. Formaldehyde is a skin and respiratory sensitizer, eye and throat irritant, and acute toxicant. Formaldehyde has been identified by NTP and IARC as a known human carcinogen (IARC 1), and by OSHA as a potential human carcinogen. Workplace exposure to formaldehyde is regulated by OSHA Standard 29 CFR 1910.1048. IARC has designated carbon black as Group 2B - inadequate evidence for carcinogenicity in humans, but sufficient evidence in experimental animals. In 2006 IARC reaffirmed its 1995 finding that there is "inadequate evidence" from human health studies to assess whether carbon black causes cancer in humans. Further, epidemiological evidence from well-conducted investigations has shown no causative link between carbon black exposure and the risk of malignant or non-malignant respiratory disease in humans. IARC has designated titanium dioxide (TiO2) as Group 2B – possibly carcinogenic to humans in dust form. However, a number of long term animal studies and human epidemiology studies evaluating TiO2 and workplace exposure show insufficient evidence for carcinogenic effects. EPA, NTP and OSHA do not designate TiO2 as a carcinogen and ACGIH designates TiO2 as A4 - not classifiable as a human carcinogen. Mortaility from other chronic diseases, including other respiratory diseases, was not associated with exposure to TiO2 dust. TiO2 is not present in this product as a dust and no airborne exposure is expected during application.